Cargando…
The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint
microRNAs (miRs) are emerging as attractive therapeutic targets because of their small size, specific targetability, and critical role in disease pathogenesis. However, <20 miR targeting molecules have entered clinical trials, and none progressed to phase III. The difficulties in miR target ident...
Autores principales: | Momin, Mohammad Yahya, Gaddam, Ravinder Reddy, Kravitz, Madeline, Gupta, Anisha, Vikram, Ajit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619171/ https://www.ncbi.nlm.nih.gov/pubmed/34831320 http://dx.doi.org/10.3390/cells10113097 |
Ejemplares similares
-
Viewpoint: Challenges and Opportunities in Tuberculosis Research
por: Kim, Peter S., et al.
Publicado: (2012) -
The microRNA‐204‐5p inhibits APJ signalling and confers resistance to cardiac hypertrophy and dysfunction
por: Gaddam, Ravinder Reddy, et al.
Publicado: (2022) -
MicroRNA-based therapeutics for optic neuropathy: opportunities and challenges
por: Mak, Heather K., et al.
Publicado: (2021) -
Potential therapeutic approaches of microRNAs for COVID-19: Challenges and opportunities
por: Farshbaf, Alieh, et al.
Publicado: (2021) -
MicroRNAs in fibrosis: opportunities and challenges
por: O’Reilly, Steven
Publicado: (2016)